Emma Walmsley
- Walmsley became CEO of GlaxoSmithKline in April of 2017, making her the first woman to run a major pharmaceutical company.
- Since taking helm of the 300-year-old company, she led a global restructuring program aimed at saving more than $500 million a year by 2021.
- The savings will be invested in R&D spending and funding a pipeline of new products.
- In one of her biggest moves since becoming CEO, Walmsley led the $13 billion dollar purchase of Novartis's 36% stake in GSK Consumer Health.
- Before joining GSK, Walmsley had a 17-year career at beauty giant L'Oreal.
